Advancing Pruritus Therapeutics With Targeted Therapies Industry Trends Gaining Momentum in the Global Pruritus Therapeutics Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Pruritus Therapeutics Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In the past few years, the pruritus therapeutics market has seen robust growth. The market size, which stands at $11.89 billion in 2024, is forecasted to increase to $12.51 billion in 2025, at a compound annual growth rate (CAGR) of 5.3%. The growth during the historic timeline is due to several factors including an increase in pruritus cases, variety in causes and conditions, the surge in the aging population, and emphasis on the quality of life for patients.

Pruritus Therapeutics Market Size Forecast: What's the Projected Valuation by 2029?
The market size of pruritus therapeutics is predicted to experience substantial growth in the coming years, expanding to $16.05 billion in 2029 with a compound annual growth rate (CAGR) of 6.4%. This growth during the forecast period can be credited to the growing understanding of pruritus pathophysiology, innovative pharmaceutical formulations and approaches, an emphasis on individualized medicine, an upsurge in dermatological studies and advancement, heightened awareness and diagnosis rates, and an increased interest in botanical and herbal therapies. Key trends for the forecast period encompass the advancement of itch-specific receptor activators and inhibitors, the market's focus on personalized therapeutic strategies, the incorporation of technology into itch management and monitoring, and partnerships for interdisciplinary research.

View the full report here:
https://www.thebusinessresearchcompany.com/report/pruritus-therapeutics-global-market-report

What Are the Drivers Transforming the Pruritus Therapeutics Market?
The pruritus therapeutics market is expected to expand due to an increase in dermatological disorders. These disorders encompass issues related to skin, hair, nail, and mucous membranes, including conditions like acne, eczema, skin cancer, and fungal infections. Itching is a common symptom, and its underlying cause often dictates the choice of pruritus treatment. Options for managing this symptom include topical treatments, emollients and moisturizers, immunosuppressive drugs, and anti-itch medications. For example, the American Cancer Society, a non-profit organization focused on eradicating cancer, predicts that there will be 108,270 skin cancer cases in January 2024. This represents a 3.2% increase from the 104,930 cases reported in 2023. Hence, higher rates of dermatological disorders are fueling the growth of the pruritus therapeutics market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11907&type=smp

What Long-Term Trends Will Define the Future of the Pruritus Therapeutics Market?
Firms with a significant presence in the pruritus therapeutics realm are currently concentrating their efforts on creating specialized treatments for specific illnesses and patient demographics. This involves the development of non-systemic ileal bile acid transport inhibitors, a type of personalized medication aimed at addressing unfulfilled medical requirements. These innovative drugs minimize absorption of bile acids in the intestine without extensively affecting the systemic circulation, thereby mitigating the potential side effects. For example, in June 2023, Ipsen, a French pharmaceutical corporation, received approval from the US-based Food and Drug Administration (FDA), a federal agency under the Department of Health and Human Services, to introduce Bylvay (odevixibat) as a treatment for cholestatic pruritus in patients 12 months and older suffering from Alagille syndrome (ALGS). Bylvay, incorporating a non-systemic ileal bile acid transport inhibitor, has scant systemic exposure and is the first-ever medication approved for cholestatic pruritus resulting from progressive familial intrahepatic cholestasis (PFIC) in the U.S. Preceding this, it had received approval as a treatment for PFIC in Europe and is now available on prescription for eligible ALGS sufferers.

Which Segments in the Pruritus Therapeutics Market Offer the Most Profit Potential?
The pruritus therapeutics market covered in this report is segmented -

1) By Product: Corticosteroids, Antihistamines, Local Anesthetics, Counterirritants, Immunosuppressants, Calcineurin Inhibitors, Other Products
2) By Route Of Administration: Oral, Parenteral, Topical
3) By Disease Type: Atopic Dermatitis, Allergic Contact Dermatitis, Urticaria, Cutaneous T-Cell, Other Disease Types
4) By End-User: Hospitals, Clinics, Other End Users

Subsegments:
1) By Corticosteroids: Topical Corticosteroids, Systemic Corticosteroids
2) By Antihistamines: First-Generation Antihistamines, Second-Generation Antihistamines
3) By Local Anesthetics: Topical Local Anesthetics
4) By Counterirritants: Menthol-Based Products, Camphor-Based Products
5) By Immunosuppressants: Topical Immunosuppressants, Systemic Immunosuppressants
6) By Calcineurin Inhibitors: Tacrolimus Ointment, Pimecrolimus Cream
7) By Other Products: Moisturizers And Emollients, Antipruritic Herbal Remedies, Combination Therapies

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=11907&type=smp

Which Firms Dominate the Pruritus Therapeutics Market by Market Share and Revenue in 2025?
Major companies operating in the pruritus therapeutics market include Pfizer Inc., Johnson & Johnson, AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, Eli Lilly and Company, Regeneron Pharmaceuticals Inc., Astellas Pharma Inc. , Bausch Health Companies Inc., Galderma Laboratories LP, Cipla Limited, LEO Pharma AS, Cara Therapeutics Inc., GlaxoSmithKline Plc, Novan Inc., Escient Pharmaceuticals Inc., Nerre Therapeutic Ltd., EPI Health LLC, Trevi Therapeutics Inc., Evelo Biosciences, Toray Medical Co. Ltd.

Which Regions Offer the Highest Growth Potential in the Pruritus Therapeutics Market?
North America was the largest region in the pruritus treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pruritus therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11907

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.